PA Leads National Crackdown on Opioid Drug Makers

The boardrooms, not just the back alleys, are now in the crosshairs of a sweeping national probe into the opioid epidemic tearing through Pennsylvania. Attorney General Josh Shapiro announced today that Pennsylvania is helping lead a multistate investigation targeting pharmaceutical companies suspected of unlawful marketing and distribution of prescription opioids—a move likened to holding Big Tobacco accountable in the 1990s.

At a hard-hitting press conference in the state Capitol, Shapiro didn’t mince words: “The people peddling the drugs ripping apart our towns aren’t only on our street corners. Three out of four heroin users started by abusing prescription opioids.” His statement underscores the shift in investigative focus—from street-level dealers to corporate executives who may have fueled mass addiction through deceptive sales practices and aggressive marketing.

Governor Tom Wolf backed the probe, stating, “I thank Attorney General Shapiro for taking a lead role in today’s action and for being a vital partner in our fight against heroin and overuse of prescription opioids.” Wolf emphasized that despite expanded treatment and law enforcement resources, overdose deaths continue to climb—proving that new tactics are urgently needed.

Lawmakers across the aisle echoed the sentiment. State Representative Gene DiGirolamo (R-Bucks), whose son battled heroin addiction, said, “I commend the decision by Attorney General Josh Shapiro to investigate the marketing and sale of opioid drugs. He’s bringing the fight against addiction to board rooms, just like he said he would.” State Senator Gene Yaw (R-Lycoming), Chair of the Center for Rural Pennsylvania, added, “Any overture related to the opioid and heroin epidemic can be a benefit to Pennsylvania.”

On the front lines, prosecutors and advocates welcomed the escalation. Somerset County District Attorney Lisa Lazzari-Strasiser called it “encouraging,” noting, “We are in a national crisis and by joining other jurisdictions we stand a better chance of making headway, cutting off this ‘epidemic’ at its roots.” Ronna Yablonski, Executive Director at the Cambria County Drug Coalition, stressed the human toll: “In a county that has experienced a 62 percent increase in fatal drug overdose deaths from 2015 to 2016, the actions taken today could not have come soon enough.”

The investigation remains active, with Pennsylvania at the helm of a bipartisan coalition of state attorneys general. No companies have been named yet, and no charges have been filed. But the message is clear: those who profited from pain may soon face a reckoning. The evidence, Shapiro vowed, “will be followed wherever it leads.”

RELATED: Alabama COVID Fraud: Dunkirk Man Admits Stealing Federal Funds

RELATED: Crypto Cash & Cocaine: DR Duo Extradited in Drug Money Scheme